Skip to main content
Premium Trial:

Request an Annual Quote

Integrated DNA Technologies: Linda De Jesus

Linda De Jesus has been appointed as VP and general manager, global head of commercial, of Integrated DNA Technologies. Most recently, she was senior VP and chief commercial officer at Azenta Life Sciences, and before that, she was VP and general manager for the chromatography and mass spectrometry division of Thermo Fisher Scientific. De Jesus holds an executive MBA from the University of Connecticut School of Business and a bachelor's degree in chemistry from Columbia University.

The Scan

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.

Study Links Evolution of Stony Coral Skeleton to Bicarbonate Transporter Gene

A PNAS paper focuses on a skeleton-related bicarbonate transporter gene introduced to stony coral ancestors by tandem duplication.

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.